Clinical characteristics and risk factors of children with influenza A complicated with different complications#br#
LIU Yang1 WANG Aibin2 SONG Meihua2 WANG Caiying1 ZHANG Yanlan1 PANG Lin1▲
1.Department of Pediatrics, Beijing Ditan Hospital Capital Medical University, Beijing 100015, China;
2.Department of Infection, Beijing Ditan Hospital Capital Medical University, Beijing 100015, China
Abstract：Objective To analyze the clinical characteristics and risk factors of children with influenza A complicated with different complications. Methods A retrospective analysis was performed on the clinical data of 1985 children under 18 years of age who were treated in the Infection Emergency Eepartment of Beijing Ditan Hospital Capital Medical University from December 2018 to February 2019, and the age distribution and clinical characteristics of children with influenza A complicated with different complications were analyzed, multivariate logistic regression was used to analyze the risk factors of different diseases associated with influenza A in children. Results Among the 437 children with influenza A complicated with other diseases, neurological diseases were the most common (10.8%), followed by pneumonia (8.0%) and bacterial infection (7.2%). The proportion of influenza-related complications was highest in children aged 1-3 years, few neurological complications occurred in children younger than 6 months, and the proportion of pneumonia was highest in children aged 1-2 years. Except for the complicated bacterial infection group, there were statistically significant differences in age distribution between the other complication groups and the simple influenza group (P < 0.05). The median age in the complication group was significantly lower than that in the simple influenza group, while the proportion of boys, the time of first visit > 48 h, the time of first nueraminidase inhibitor (NAI) > 48 h, and complicated underlying diseases were significantly higher than those in simple influenza group (P < 0.05). Age, sex, underlying diseases, and time of first NAI > 48 h were the risk factors of children with influenza complicated with different complications (OR > 1, P < 0.05). Compared with children aged 5-17 years, the risk of influenza-related complications in other age groups were significantly higher, and the risk of complications in children aged 1-3 years was 3.330 times higher than that in children aged 5-17 years. The risk of neurological complications in children aged 1-5 years was higher, and the risk of neurological complications in children with underlying diseases was 4.691 times higher than that in children without underlying diseases (P < 0.05). The risk of pneumonia was higher in 0-3 years old, male, complicated with underlying diseases and time of first NAI > 48 h (P < 0.05). However, influenza complicated with bacterial infection mostly occurred in children under 5 years old, combined with underlying diseases and time of first NAI > 48 h were independent risk factors (P < 0.05). Conclusion Nervous system diseases, pneumonia and bacterial infection are the most common complications of influenza in children. Male, children under 5 years old, complicated with underlying diseases and delayed antiviral treatment for more than 48 h after onset are the high risk factors of influenza complicated with other diseases.
刘洋1 王爱彬2 宋美华2 王彩英1 张艳兰1 庞琳1▲. 儿童甲型流感合并不同并发症的临床特征及其危险因素分析[J]. 中国医药导报, 2021, 18(33): 102-106.
LIU Yang1 WANG Aibin2 SONG Meihua2 WANG Caiying1 ZHANG Yanlan1 PANG Lin1▲. Clinical characteristics and risk factors of children with influenza A complicated with different complications#br#. 中国医药导报, 2021, 18(33): 102-106.
[1] World Health Organization. Influenza（Seasonal）[EB/OL].[2018-09-10]. http：//www.who.int/news-room/detail/14-12-2017.
[2] Dananché C，Picot VS，Bénet T，et al. Burden of influenza in less than 5-year-old children admitted to hospital with pneumonia in developing and emerging countries [J]. Am J Trop Med Hyg，2018，98（6）：1805-1812.
[3] Dawood FS，Fiore A，Kamimoto L，et al. Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza，2003-2008 [J]. Pediatr Infect Dis J，2010， 29（7）：585-594.
[4] 国家卫生健康委办公厅，国家中医药管理局办公室.流行性感冒诊疗方案（2020年版）[J].传染病信息，2020，33（5）：385-390.
[5] Demir S?魻，At?覦c?覦 S，Kadayifci EK，et al. Influenza A-associated severe complications；hemolytic uremic syndrome，myocarditis，acute necrotizing encephalopathy [J]. J Infect Dev Ctries，2019，13（1）：83-86.
[6] 彭质斌，许军，余昭，等.中国10省（市）2009-2014年15岁以下儿童流感确诊住院病例严重急性呼吸道感染临床特征及其危险因素分析[J].中华流行病学杂志，2015， 36（3）：210-215.
[7] Chong CY，Yung CF，Gan C，et al. The burden and clinical manifestation of hospitalized influenza among different pediatric age-groups in the tropics [J]. Influenza Other Respir Viruses，2020，14（1）：46-54.
[8] Paksu MS，Aslan K，Kendirli T，et al. Neuro influenza：evaluation of seasonal influenza associated severe neurological complications in children [J]. Childs Nerv Syst，2018，34（2）：335-347.
[9] Ram Purakayastha D，Vishnubhatla S，Rai SK，et al. Estimation of burden of influenza among under-Five children in India：a Meta-Analysis [J]. J Trop Pediatr，2018，64（5）：441-453.
[10] Yu J，Zhang X，Shan W，et al. Influenza-associated hospitalization in children younger than 5 years of age in Suzhou，China，2011-2016 [J]. Pediatr Infect Dis J，2019， 38（5）：445-449.
[11] Lee JJ，Bankhead C，Smith M，et al. Risk factors for influenza-related complications in children during the 2009/10 pandemic [J]. Epidemiol Infect，2018，146（7）：817-823.
[12] Mastrolia MV，Rubino C，Resti M，et al. Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in a tertiary pediatric hospital in Italy [J]. BMC Infect Dis，2019，19（1）：1-10.
[13] Britton PN，Blyth CC，Macartney K，et al. The spectrum and burden of influenza-associated neurological disease in children，2013-2015 [J]. Clin Infect Dis，2017，65（4）：653-660.
[14] 唐源，张光莉，罗斯颖，等.重庆医科大学附属儿童医院甲型流感病毒肺炎患儿 617 例临床特征及重症危险因素分析[J].中国实用儿科杂志，2019，12（34）：1017-1021.
[15] Kendirli T，Demirkol D，Yldzdas D，et al. Critically ill children with pandemic influenza in pediatric intensive care units in Turkey [J]. Pediatr Crit Care Med，2012，13（1）：e11-e17.
[16] 于芹，周慧，张涛，等.儿童流行性感冒相关死亡病例临床特点及危险因素分析[J].中华儿科杂志，2020，58（11）：910-916.
[17] Chowell G，Viboud C，Simonsen L，et al. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico [J]. BMC Infect Dis，2012，12（1）：1-11.
[18] Homaira N，Briggs N，Oei JL，et al. Impact of influenza on hospitalization rates in children with a range of chronic lung diseases [J]. Influenza Other Respir Viruses，2019， 13（3）：233-239.
[19] Ghimire LV，Moon-Grady AJ. Among Pediatric Patients Hospitalized for Influenza Infection，Pre-Existing Cardiomyopathy Confers Significantly Higher Morbidity and Mortality [J]. Am J Cardiol，2020，137：138-139.
[20] Tramuto F，Restivo V，Costantino C，et al. Surveillance Data for Eight Consecutive Influenza Seasons in Sicily，Italy [J]. Am J Trop Med Hyg，2019，101（6）：1232-1238.
[21] Yokomichi H，Mochizuki M，Lee JJ，et al. Incidence of hospitalisation for severe complications of influenza virus infection in Japanese patients between 2012 and 2016 [J]. BMJ Open，2019，179（1）：e024687.
[22] Tagarro A，Cruz-Ca?觡ete M，Otheo E，et al. Oseltamivir for the treatment of influenza in children and adolescents [J]. An Pediatr（Engl Ed），2019，90（5）：317.e1-317.e8.
[23] 徐翠玲，袁帆，陈敏，等.中国2009-2010年18岁以下人群甲型H1N1流感相关肺炎住院病例危险因素分析[J].中华流行病学杂志，2012，33（4）：404-408.
[24] Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children，2020-2021 [J]. Pediatrics，2020，146（4）：e2020024588.
京公网安备 11010502046598号